Skip to main content

New compounds block master regulator of cancer growth, metastasis


Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes. The new compounds suppress tumor growth in human cells and in mouse models of several types of human breast cancer.

The researchers report their findings in the journal NPJ Breast Cancer.

News Archive
Subscribe to Yvonne Ziegler